First‐in‐class cardiolipin‐protective compound as a therapeutic agent to restore mitochondrial bioenergetics

HH Szeto - British journal of pharmacology, 2014 - Wiley Online Library
A decline in energy is common in aging, and the restoration of mitochondrial bioenergetics
may offer a common approach for the treatment of numerous age‐associated diseases …

[PDF][PDF] Themed Issue: Mitochondrial Pharmacology: Energy, Injury & Beyond

British Journal of Pharmacology, 2029 - researchgate.net
Defects in energy metabolism represent a common thread among many age-associated
complex diseases. A decline in bioenergetics underlies the general frailty of old age and a …

First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics.

HH Szeto - British Journal of Pharmacology, 2014 - europepmc.org
A decline in energy is common in aging, and the restoration of mitochondrial bioenergetics
may offer a common approach for the treatment of numerous age-associated diseases …

[HTML][HTML] First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics

HH Szeto - British Journal of Pharmacology, 2014 - ncbi.nlm.nih.gov
A decline in energy is common in aging, and the restoration of mitochondrial bioenergetics
may offer a common approach for the treatment of numerous age-associated diseases …

[引用][C] First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics

HH Szeto - British Journal of Pharmacology, 2014 - cir.nii.ac.jp
First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial
bioenergetics | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …

First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics

HH Szeto - British journal of pharmacology, 2014 - pubmed.ncbi.nlm.nih.gov
A decline in energy is common in aging, and the restoration of mitochondrial bioenergetics
may offer a common approach for the treatment of numerous age-associated diseases …

First‐in‐class cardiolipin‐protective compound as a therapeutic agent to restore mitochondrial bioenergetics

HH Szeto - British Journal of Pharmacology, 2014 - infona.pl
A decline in energy is common in aging, and the restoration of mitochondrial bioenergetics
may offer a common approach for the treatment of numerous age‐associated diseases …

First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics.

HH Szeto - British Journal of Pharmacology, 2014 - europepmc.org
A decline in energy is common in aging, and the restoration of mitochondrial bioenergetics
may offer a common approach for the treatment of numerous age-associated diseases …